Chesnara Plc: Acquisitions show immediate benefits
2 September 2026
GeneDx Holdings Corp. (NASDAQ: WGS), a prominent player in the Diagnostics & Research sector, is capturing attention with its robust 45.60% revenue growth and a market capitalization of $3.45 billion...
Amedisys Inc (NASDAQ: AMED), a prominent player in the healthcare sector, continues to capture investor interest with its strong focus on home health services, hospice care, and high acuity care...
UFP Technologies, Inc. (NASDAQ: UFPT), a prominent player in the healthcare sector, specifically within the medical devices industry, has caught the attention of investors with its robust growth metrics and..
Veracyte, Inc. (VCYT), a prominent player in the healthcare sector, specializes in groundbreaking diagnostic solutions that span multiple types of cancer. With a market capitalization of $2.84 billion, the company..
Alvotech (NASDAQ: ALVO), a Luxembourg-based biopharmaceutical company, continues to pique investor interest with its innovative approach to biosimilar medicines and a remarkable potential upside. Operating in the highly competitive healthcare..
PROCEPT BioRobotics Corporation (NASDAQ: PRCT), a key player in the healthcare sector specializing in medical devices, presents an intriguing opportunity for investors with its promising position in the surgical robotics..
Arcellx, Inc. (NASDAQ: ACLX), a pioneering biotechnology firm based in Redwood City, California, is making significant strides in the healthcare sector with its innovative immunotherapy developments. Despite a recent slight..
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX), a prominent player in the healthcare sector, is drawing attention from investors with a robust market capitalization of $3.31 billion. The company, rooted in the..
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), a prominent player in the biotech sector, is drawing investor attention with its promising therapeutic pipeline and a market cap of $3.64 billion. The company,..
Travere Therapeutics, Inc. (NASDAQ: TVTX) stands out in the biotechnology sector as a promising player with a focus on rare kidney and metabolic diseases. With a market capitalization of $2.33..
Investors with an appetite for high-growth potential in the biotechnology sector might find ARS Pharmaceuticals, Inc. (SPRY) an intriguing opportunity. This San Diego-based biopharmaceutical company specializes in innovative treatments for..
CONMED Corporation (NASDAQ: CNMD), a prominent player in the medical devices industry, has captured investor attention with its potential upside of 31.27%, as evidenced by the average analyst target price..
Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a promising player in the biotechnology sector, is drawing investor attention with its robust clinical pipeline focused on muscle disorders and a significant potential upside..
Enovis Corporation (NYSE: ENOV), a prominent player in the healthcare sector specializing in medical devices, is currently capturing the attention of investors with a compelling potential upside of 58.88%. With..
Celldex Therapeutics, Inc. (NASDAQ: CLDX) stands at the forefront of biotechnology innovation, carving out a niche in the development of therapeutic antibodies aimed at addressing severe inflammatory, allergic, autoimmune, and..
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) stands as a formidable player in the biotech industry, boasting a robust market capitalization of $3.56 billion. Based in Jupiter, Florida, Ligand is renowned for..
Investors focused on the healthcare sector might want to keep an eye on National HealthCare Corporation (NHC), a key player in the medical care facilities industry. With a market capitalization..
Indivior PLC (INDV), a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, presents an intriguing opportunity for investors seeking growth potential. Headquartered in..
GoodRx Holdings, Inc. (NASDAQ: GDRX) is an intriguing player in the healthcare sector, specifically within health information services. With a market capitalization of $1.59 billion, this Santa Monica-headquartered company has..
For investors with a keen eye on the healthcare sector, PACS Group, Inc. (PACS) presents an intriguing opportunity. With its operations entrenched in the medical care facilities industry, PACS Group..
